About GC Genome
GC Genome is a publicly listed company based in Yongin (South Korea) founded in 2013. Developer of genomic diagnostic tests for multiple diseases. The company has 125 employees. Its chief executive, as recorded, is Chang-Seok Ki. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
GC Genome was founded in 2013 as a developer in the genomics sector. Next-generation sequencing tests are offered for precision oncology, rare diseases, prenatal and neonatal health, gut analysis, and related areas. Operations focus on diagnostic services across multiple disease categories, with leadership provided by CEO Chang-Seok Ki. The company maintains a presence through its domain gc-genome.com.
- Headquarters Yongin, South Korea
- Employees 125
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gc-genome.com
- Social LinkedIn Facebook
- Legal Name Gc Genome Corp.
- Annual Revenue$21.83 M (USD)21.81as on Dec 31, 2025
- Net Profit$2.8 M (USD)as on Dec 31, 2025
- EBITDA$2.84 M (USD)119.68as on Dec 31, 2025
- Employee Count125
People of GC Genome
1 people are tracked at GC Genome (1 in leadership); the tracked headcount is 125.
| Name | Role | Group |
|---|---|---|
Chang-Seok Ki | CEO | Leadership |
Complete people profiles for GC Genome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of GC Genome
GC Genome is a publicly listed company on the KRX with ticker symbol 340450 in South Korea, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Jun 2025
- Listed onKRX: 340450
- Listed entityGC Genome Corp.
- Exchange sectorHealth services
- ISINKR7340450006
- Share price8,850.00 KRW (-7.62% on the day) · 2026-10-14
- Market capitalisation226,574,597,664.00 KRW
- Price to earnings38.7
- EPS (diluted, trailing year)228.96 KRW
- Volume (last session)552,355
Financials of GC Genome
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 31.53B KRW | 4.04B KRW | 4.10B KRW |
| 2024 | 25.89B KRW | -1.26B KRW | 1.87B KRW |
| 2023 | 27.29B KRW | -550.1M KRW | 3.70B KRW |
| 2022 | 24.11B KRW | -3.76B KRW | -1.58B KRW |
| 2021 | 18.50B KRW | 293.2M KRW | -51.9M KRW |
Detailed financial statements for GC Genome
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of GC Genome
The website of GC Genome (gc-genome.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▼ 2.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gc Genome
Complete news archive for GC Genome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GC Genome
GC Genome was founded in 2013.
GC Genome is headquartered in Yongin, South Korea. It is registered at Yongin, Gyeonggi, South Korea.
Chang-Seok Ki is the CEO of GC Genome, as recorded in our data.
GC Genome has 125 employees.
Annual revenue of GC Genome is $21.83M as on Dec 31, 2025.
GC Genome was founded in 2013 as a developer in the genomics sector. Next-generation sequencing tests are offered for precision oncology, rare diseases, prenatal and neonatal health, gut analysis, and related areas. Operations focus on diagnostic services across multiple disease categories, with leadership provided by CEO Chang-Seok Ki. The company maintains a presence through its domain gc-genome.com.
Yes, GC Genome is publicly traded on KRX under the ticker symbol 340450.